Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07820891 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395

Name: A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395 — clinical trial record (NCT07820891)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorBeOne Medicines

Started2026-09-24

View on ClinicalTrials.gov ↗

BeOne Medicines

59 trials monitored

See 7 trials at risk

This study will enroll healthy participants to evaluate whether BGB-43395 interacts with other drugs, including midazolam, celecoxib, dabigatran, and rosuvastatin.

Trial Details

NCT Number	NCT07820891
Lead Sponsor	BeOne Medicines Collaborators: Fortrea
Conditions	Healthy Adult Participants
Enrollment	24 participants
Start Date	2026-09-24
Primary Completion	2026-11-22 (estimated)
Study Completion	2026-11-22 (estimated)
Updated on ClinicalTrials.gov	2026-09-15